A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

Overview of attention for article published in Journal of Bone & Mineral Research, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 6 X users

wikipedia: 2 Wikipedia pages

Readers on

mendeley: 165 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 9,787 followers.

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density - Recker - 2015 - Journal of Bone and Mineral Research - Wiley Online Library イーライリリー？の方が研究進んでる…

Nuevas armas para la osteoporosis: Blosozumab en rampa de despegue http://t.co/2kyNpmcC3M

#JBMR®: A Randomized Phase 2 Clinical Trial of Blosozumab in Postmenopausal Women with Low Bone Mineral Density http://t.co/o1GoExi6Xs

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.